Measles virus. Courtesy of the CDC.
Â
The U.S. measles vaccination program has been successful in eliminating endemic measles in the United States; yet this success has provided challenges that require ongoing vigilance for the rapid identification and response to measles cases in healthcare settings. In 2008, the largest reported healthcare-associated measles outbreak in the United States since 1989 occurred in Tucson, Ariz., costing approximately $800,000 in response and containment efforts.
In a report published in the Journal of Infectious Diseases and available online, researchers identify preventive measures hospitals and healthcare facilities can implement to reduce the likelihood and decrease the economic impact of a future measles outbreak in these settings.
Due to a highly effective vaccine and high vaccine coverage, measles was declared eliminated in the United States in 2000; however, the potential for measles infection still exists in this country. Non-adherence to U.S. vaccination recommendations and infection among unvaccinated travelers coming into the United States continue to pose potential threats to the public and to healthcare personnel. In the 2008 Tucson outbreak, an unvaccinated, infected Swiss traveler visited a hospital emergency department on Feb. 12. The traveler was admitted to the hospital the next day, but a measles diagnosis was not confirmed until Feb. 20. This ignited an intense and lengthy public health investigation and response to persons with suspected and confirmed measles as well as contacts of those persons.
From Feb. 13 through July 21, 2008, there were 363 suspected, eight probable, and 14 confirmed measles cases in Tucson. All 14 confirmed case-patients were unvaccinated. Seven of the 14 cases were classified as healthcare-associated infections, and six of those cases occurred in a single hospital. Healthcare-associated transmission included transmission from patient to healthcare personnel, from healthcare personnel to patient, from patient to patient, and from patient to visitor.
As part of the investigation, healthcare facilities attempted to access records documenting evidence of measles immunity for 14,844 healthcare personnel at seven hospitals. However, none of the hospitals maintained electronic records of health care personnel immunity status, so they were instead forced to review paper records. Without readily accessible electronic records clearly showing immunity status, unnecessary serologic testing was conducted for some personnel who were immune to measles. A total of 4,448 healthcare personnel at the seven hospitals received immediate measles vaccinations because they lacked documentation of measles immunity. About 15,120 employee hours were lost in furloughs because of presumptive exposure, disease, or lack of evidence of immunity. Overall, the estimated economic impact for just two of the hospitals was almost $800,000, with furloughs for health care personnel accounting for 56 percent of that cost.
In this report, Sanny Y. Chen, PhD, along with colleagues at the Centers for Disease Control and Prevention (CDC) and Arizona health authorities show the high costs hospitals can incur when responding to measles outbreaks in their facilities. To minimize these costs and to prevent the healthcare-associated spread of measles, they stress that hospitals must ensure rapidly retrievable measles immunity records for healthcare personnel, consider measles as a diagnosis, especially among patients presenting with fever, rash, and a recent history of international travel or contact with a person with a clinically consistent rash illness, and institute immediate airborne isolation of patients with suspected and confirmed measles.
The authors believe that a number of factors contributed to the Tucson outbreak, including the following:
- lack of adherence to U.S. vaccine policy recommendations
- delayed implementation of infection-control procedures in healthcare settings with patients/personnel experiencing respiratory symptoms
- delayed implementation of isolation procedures in healthcare settings with patients with an illness clinically compatible with measlesÂ
- delayed diagnosis of cases by healthcare personnel and delayed laboratory confirmation due to lack of awareness of measles.
In an accompanying editorial, Stephen M. Ostroff, MD, of the Pennsylvania Department of Health, calls the report a sobering wake-up call for health departments and hospitals across the country. Recounting the percentage of healthcare personnel who lacked immunity to measles in the Tucson outbreak, Ostroff concludes that the same situation most likely exists among other U.S. hospital personnel. International travel and the decision by some individuals to opt out of vaccination increase the risk of future outbreaks, he notes.
The editorial emphasizes major challenges in measles in the post-elimination era in the United States: late diagnosis of cases and delayed reporting to the health department. Prompt reporting of the suspected case could have prevented the spread of infection and minimized the expense incurred to investigate the outbreak, notes Ostroff, who adds that it is essential to prevent healthcare personnel from acting as vehicles of infection transmission to others by ensuring that all staff are appropriately vaccinated unless they have other acceptable evidence of measles immunity.
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.